5-Deoxykaempferol Plays a Potential Therapeutic Role by Targeting Multiple Signaling Pathways in Skin Cancer
Authors:
Open Access
- 1 April 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 3 (4) , 454-465
Abstract
Nontoxic small molecules with multitargeting effects are believed to have potential in cancer prevention. Dietary phytochemicals were shown to exhibit cancer-preventive effects attributed to their antioxidant capacities. In this report, we show that the natural compound 5-deoxykaempferol (5-DK) exerts a chemopreventive effect on UVB-induced skin carcinogenesis by targeting multiple signaling molecules. 5-DK suppressed the UVB-induced expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor in mouse skin epidermal JB6 P+ cells. Moreover, 5-DK inhibited phosphorylation of MKK3/6, MKK4, and Akt, but had no effect on phosphorylation of Src, extracellular signal–regulated kinases, or ribosomal S6 kinase (RSK). However, 5-DK affected multiple targets by reducing Src, phosphoinositide 3-kinase (PI3K), and RSK2 activities. In particular, pull-down assays revealed that 5-DK specifically bound to and competed with ATP for binding with Src, PI3K, and RSK2. Exposure to 5-DK significantly suppressed UVB-induced tumorigenesis in mouse skin in a dose-dependent manner, and it inhibited the UVB-induced expression of COX-2, proliferating cell nuclear antigen, vascular endothelial growth factor, and matrix metalloproteinase-9. Our data suggest that 5-DK docks at the ATP-binding site of Src, PI3K, and RSK2. For RSK2, the ATP-binding site is located between the N- and C-lobes of the kinase domain. Taken together, our results indicate that 5-DK holds promise for the treatment of UVB-induced skin cancer by targeting Src, PI3K, and RSK2 signaling. Cancer Prev Res; 3(4); 454–65. ©2010 AACR.Keywords
This publication has 27 references indexed in Scilit:
- Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2Nature Structural & Molecular Biology, 2007
- Ribosomal S6 Kinase 2 Is a Key Regulator in Tumor Promoter–Induced Cell TransformationCancer Research, 2007
- The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)British Journal of Dermatology, 2007
- Comparing antibody and small-molecule therapies for cancerNature Reviews Cancer, 2006
- Crystal Structures of Active Src Kinase Domain ComplexesJournal of Molecular Biology, 2005
- Photochemoprevention of ultraviolet B signaling and photocarcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Cellular and molecular events leading to the development of skin cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- The Hallmarks of CancerCell, 2000
- CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASESAnnual Review of Cell and Developmental Biology, 1997